Evidence map›Paper›PMID 30478383›Full record

ArticleCell death and differentiation2019

Dclk1 in tuft cells promotes inflammation-driven epithelial restitution and mitigates chronic colitis.

Jun Yi, Kirk Bergstrom, Jianxin Fu, Xindi Shan, J Michael McDaniel, Samuel McGee, Dongfeng Qu, Courtney W Houchen, Xiaowei Liu, Lijun Xia

Open access · bronzeAbstract read
In one paragraph

Article in Cell death and differentiation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed, 1 pooled it
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 1 synthesis or guideline pooled it, 94 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Jun YiDepartment of Gastroenterology, Xiangya Hospital of Central South University, Changsha, Hunan, 410008, China.
Kirk BergstromCardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 73104, USA.
Jianxin FuCardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 73104, USA.ORCID 0000-0002-3067-8539
Xindi ShanCardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 73104, USA.
J Michael McDanielCardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 73104, USA.
Samuel McGeeCardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 73104, USA.
Dongfeng QuDepartment of Internal Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA.
Courtney W HouchenDepartment of Internal Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA.
Xiaowei LiuDepartment of Gastroenterology, Xiangya Hospital of Central South University, Changsha, Hunan, 410008, China. liuxw@csu.edu.cn.
Lijun XiaCardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 73104, USA. Lijun-Xia@omrf.org.ORCID 0000-0002-9586-7971
Oklahoma Medical Research Foundation · USCentral South University · CNUniversity of Oklahoma Health Sciences Center · US

Funding

Pilot ProjectP30GM114731 · NIGMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI MCEVER, RODGER PAUL · 2016 to 2020
$6.5M
Role of Mucin-type O-glycans in Intestinal InflammationR01DK085691 · NIDDK · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI David Casero, Lijun Xia · 2010 to 2026
$6.2M
Platelet CLEC-2 regulation of vascular integrity during inflammationR01HL128390 · NHLBI · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI MCEVER, RODGER PAUL, XIA, LIJUN · 2016 to 2019
$1.7M
NHLBI NIH HHS R01 HL128390NIDDK NIH HHS R01 DK085691NIGMS NIH HHS P30 GM114731
6 · The paper itself

Abstract

Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterized by defective intestinal barrier integrity toward the microbiota and epithelial damage. Double cortin-like kinase 1 (Dclk1), a marker of intestinal tuft cells, can regulate tissue regenerative responses, but its role in epithelial repair during bacterial-dependent chronic colitis is unclear. We addressed this question using our recently developed mouse model of spontaneous microbiota-dependent colitis induced by mucin-type O-glycan deficiency (DKO), which recapitulates most features of human UC. We generated DKO mice lacking intestinal epithelial Dclk1 (DKO;Dclk1

Indexed as

AnimalsApoptosisCell ProliferationChronic DiseaseColitisColonDisease Models, AnimalDoublecortin-Like KinasesEpithelial CellsHumansInflammationIntestinal MucosaMiceMice, KnockoutProtein Serine-Threonine KinasesSignal TransductionDclk1 protein, mouseDoublecortin-Like KinasesProtein Serine-Threonine Kinases

Identifiers

PMID30478383
PMCPMC6748088
OpenAlexW2902064666

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.